TomoTherapy Inc. is a publicly-traded company under (NASDAQ:TOMO), it is based in the U.S. with European offices in Belgium and distribution throughout the world. The company owns multiple issued U.S. patents and has a number of patent applications pending, both in the U.S. and worldwide. The company also holds an exclusive license on more than 100 issued patents and pending applications globally.